Clinical Trials Browser

Phase 2 × Fulvestrant × Genitourinary × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT04557449 2025-10-01

CDK4i

Phase 2 Active not recruiting

BreastGastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma of Lung, Breast Neoplasms, Liposarcoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT00476645 2014-08-05

Fulvestrant in Hormone Refractory Prostate Cancer

Phase 2 Completed

10 enrolled 8 charts

Prostatic Neoplasms

NCT00244998 2013-03-08

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms